Skip to main content
Infection and Drug Resistance logoLink to Infection and Drug Resistance
. 2019 May 13;12:1171–1180. doi: 10.2147/IDR.S196575

Association of the genes encoding Metallo-β-Lactamase with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter baumannii

Mansour Amin 1,2, Tahereh Navidifar 2, Farkhondeh Saleh Shooshtari 2,, Hamed Goodarzi 2
PMCID: PMC6526166  PMID: 31190906

Abstract

Background: Metallo-β-Lactamases (MBL) are usually encoded on the gene cassettes harboring integrons and disseminated easily among Acinetobacter baumannii isolates. This study was aimed to investigate the association of the genes encoding MBL with the presence of class 1 and 2 integrons among multidrug-resistant (MDR) A.baumannii isolates.

Methodology: A total of 85 non-duplicated A.baumannii isolates were collected and evaluated for the amplification of blaOXA-51. The presence of genes encoding MBLs, including blaIMP, blaVIM, blaSIM, blaSPM, blaGIM, blaDIM and blaNDM, as well as intI 1 and intI 2 was evaluated by PCR. Also, the production of MBLs was screened phenotypically by the combination of EDTA and meropenem.

Results: In this study, 77 out of 85 isolates were MDR. Also, 34 isolates had only intI 1, 10 had only intI 2 and 15 had both intI 1 and intI 2. The phenotypic detection of MBLs was found in 30 isolates, among which blaVIM was as the most common the gene encoding MBL followed by blaIMP, blaSPM and blaSIM. The gene cassettes analysis revealed that class 1 integron is often responsible for transferring the genes harboring MBLs.

Conclusion: The production of MBLs among A. baumannii strains is one of the main mechanisms of resistance to carbapenems. Therefore, the development of inexpensive screening methods for the phenotypic detection of MBLs in clinical laboratories settings is essential. Also, our data revealed that the class 1 integron is often responsible for the dissemination of the MBL genes among A. baumannii isolates.

Keywords: acinetobacter baumannii, blaVIM, blaIMP, integron, Metallo-Beta-Lactamase

Introduction

Multidrug-resistant (MDR) bacterial strains have emerged as one of the leading causes of nosocomial infections worldwide. Infections caused by A. baumannii are frequent and increasing in hospitalized patients, especially in the intensive care units (ICU).1 Nowadays, the development of antibiotic resistance among A. baumannii strains is considered as one of the major public health concerns in hospital setting.2 Moreover, A. baumannii strains have a high capacity to acquire the multiple antibiotic resistance determinants through the mobile elements, such as integrons harboring single or multiple gene cassettes.

Integrons are conserved, transposon-like DNA elements that mostly encode antibiotic resistance determinants and have a high ability for chromosomal integration in bacteria.3 To date, several classes of integrons have been described; among them, class 1 and 2 integrons are frequently reported from MDR A. baumannii strains.4,5

Carbapenems have a potent activity against multidrug-resistant gram-negative bacilli and are usually the choice antibiotics against A.baumannii strains. However, the resistance rate to carbapenems in this bacterium is increasing throughout the world. The resistance to carbapenems can be led through various mechanisms, such as the production of Metallo-β-Lactamase and oxacillinase enzymes.6

More specially, the infections caused by Metallo-Beta-Lactamase (MBL)-producing organisms are associated with the high rates of morbidity and mortality.7 MBLs belong to class B beta-lactamases that can hydrolyze all beta-lactam classes except monobactams.8 MBLs are usually encoded on the gene cassettes harboring class 1 integron and disseminated easily in bacterial populations.9 To date, several MBLs were recognized such as the blaVIM, blaIMP, blaGIM, blaSPM, blaDIM, blaSIM and blaNDM which of those, the blaVIM and blaIMP allelic variants have emerged as the dominant MBLs worldwide.8,10 The high levels of resistance to carbapenems among MDR A. baumannii strains have made some demands for the reintroduction older antibiotics such as colistin and polymyxin B that had not been used for many years because of their toxicity.11 Moreover, recent studies have shown that gram-negative bacilli resistant to aminoglycosides, beta-lactams, and fluoroquinolones are often sensitive to polymyxin B.12 This study was aimed to investigate the association of the genes encoding MBLs with the presence of integrons among multidrug-resistant clinical isolates of Acinetobacter Baumannii.

Materials and methods

Bacterial isolates and identification

The present study was conducted from July 2017 to March 2018. A total of 85 A.baumannii clinical isolates were collected from different clinical samples of hospitalized patients in hospitals of Imam Khomeini and Taleghani in Ahvaz, Iran. The collected samples were as part of the routine hospital laboratory procedure and were transferred to Department of Microbiology, school of medicine, Ahvaz Jundishapur University of Medical Sciences. Then, they were cultured on Blood agar and MacConkey agar (Merck–Germany) and incubated for 24 hrs at 37°C. The gram-negative bacilli were monitored for more biochemical tests, including the sugar fermentation, motility, citrate utilization, urease, oxidative/fermentative glucose (O/F) test, catalase, oxidase and growth ability at 37°C and 42°C.13In addition, the identification of A. baumannii isolates was confirmed by the amplification of blaOXA-51-like gene using the previously described primers by Turton et al.14 The A. baumannii ATCC19606 was used as the reference strain.

Antibiotic susceptibility testing

Antimicrobial susceptibility of A. baumannii isolates was determined by disc diffusion method according to the clinical and laboratory standards institute (CLSI) guidelines.15 Briefly, the bacterial suspensions were prepared in sterile normal saline to a turbidity equivalent of 0.5 McFarland standard. The used antibiotic discs were imipenem (10 μg), meropenem (10 μg), ceftazidime (30 μg), cefotaxime (30 μg), ciprofloxacin (5 μg), gentamicin (10 μg), amikacin (30 μg), tetracycline (30 μg), piperacillin (100 μg), cefepime(30 μg), piperacillin/tazobactam (100/10 μg), trimethoprim/sulphamethoxazole (1.25/23.75 μg), colistin (10 μg), ampicillin/sulbactam (10/10 μg), ceftriaxone (30 μg) and polymexin B (300U). Then, after 24 h incubation the diameters of the inhibition zones were measured in millimeters. Also, the minimum inhibitory concentrations (MICs) of colistin, meropenem and imipenem were measured using broth microdilution method and their results were interpreted according to CLSI (2018).15 In brief, for meropenem and imipenem, a MIC ≥8 µg/ml is considered as the breakpoint of resistant, as well as a MIC ≥4 µg/ml for colistin.

MDR Acinetobacter isolates are defined as strains that were resistant to at least three classes of antimicrobial agents, including all penicillins and cephalosporins, fluoroquinolones and aminoglycosides.16

Phenotypic detection of MBL production

First, the bacterial suspensions adjusted to 0.5 McFarland were streaked on Mueller Hinton agar plates using the Dacron swab. Then, two discs of meropenem (10 μg), one with 5 μL of 0.35 M EDTA and the other without EDTA were placed on a Mueller Hinton agar plate and incubated at 37°C for 16–18 hrs. The discs containing EDTA alone served as the negative control. A strain was considered to be MBL positive, if there was an increase of ≥7 mm in the inhibition zone around the imipenem + EDTA disc as compared to imipenem disc alone.17

ERIC-PCR typing and analysis

The genetic relationship of A. baumannii isolates was determined using the enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR)18 with the primers sequences of ERIC-F (5′-ATGTAAGCTCCTGGGGATTCAC-3) and ERIC-R (5′AAGTAAGTGACTGGGGTGA GCG-3′). The PCR reaction was performed in the final volume of 25 µL as follows: 1U Taq DNA polymerase, 1.5 mM MgCl2, 200 μM dNTPs, 0.35 μM of each primer, 10x PCR buffer, 6.5 μL of template DNA and distilled water up to a final volume of 25 μL. The amplification process was performed in Mastercycler Nexus Thermal Cycler Gradient (Eppendorf, Hamburg, Germany) with one cycle of initial denaturation at 94°C for 5 mins, followed by 35 cycles of denaturation at 94°C for 60 s, annealing at 57°C for 60 s, extension at 72°C for 80 s and a cycle of final extension at 72°C for 10 mins. The amplified products were visualized on agarose gel 1.5%, stained with safe stain. The data analysis was performed using the Gel Compare II software version 6.6 (Applied Math, Sint-Martens-Latem, Belgium). The similarity pattern was calculated using the Unweighted-Pair Group Method (UPGMA)/the Dice similarity coefficient with a position tolerance of 1%. Isolates with more than 90% similarity were considered as a clonal type.

Molecular method

The whole genomes of all MDR A. baumannii isolates were extracted using High Pure PCR Template Preparation Kit (Roche Diagnosis, Mannheim, Germany) according to manufacturer’s procedure. The Uniplex PCR reactions were performed for the presence of genes encoding intI1, intI2, blaIMP, blaVIM, blaDIM, blaGIM, blaSIM, blaNDM and blaSPM in a final volume of 25 μL, as described previously.1922 In each PCR run, the distilled water was used as the negative control. The reaction mixture consisted of 1 U of AmpliTaq DNA polymerase, 1X PCR buffer, 1.5 mM MgCl2, 200 µM dNTPs, 3 μL of DNA and distilled water up to a final volume of 25 μL. The primer concentrations were as follows: 0.2 pmol/µL each of primers IntI1-F, IntI1-R, IntI2-F and IntI2-R; 0.45 pmol/µL each of primers blaVIM -F, blaVIM-R, blaIMP-F and blaIMP -R; 0.25 pmol/µL each of primers blaGIM-F, blaGIM-R, blaDIM-F and blaDIM-R; and 0.45 pmol/µL each of primers blaSIM-F, blaSIM-R, blaNDM-F, blaNDM-R, blaSPM-F and blaSPM-R. The amplification process was performed in a Mastercycler Nexus Thermal Cycler Gradient (Eppendorf, Hamburg, Germany) with one cycle initial denaturation at 95°C for 5 mins; 35 cycles with a denaturation temperature of 95°C for 45 s; annealing temperature of 51°C for the IntI1 and IntI2 genes, 54°C for the blaIMP and blaVIM genes, 53°C for the blaOXA-51-like gene, 52°C for the blaGIM, blaSIM and blaSPM genes, as well as 58°C for the blaNDM and blaDIM genes for 30 s and extension temperature of 72°C for 30 s, followed by a cycle of final extension at 72°C for 10 mins. All of the PCR products were visualized on 1% agarose gel stained with safe stain. DNA sequencing of PCR products was performed by (Bioneer, South Korea) for the determination of the MBL allelic variants.

Sequencing of integron gene cassettes

Amplification of the variable region of class 1 and 2 integrons was performed, as previously by Moura et al23. Then, the purification of the PCR products was performed by the QIAquick Gel Extraction Kit (Qiagen, Germany) and subjected to sequencing with an ABI Prism 377 automated sequencer (Applied Biosystems, USA). The obtained sequences were assembled using MEGA 724 and compared with those in the NCBI database using a BLAST program (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and the integron database INTEGRALL (http://integrall.bio.ua.pt/).

Statistical analysis

The descriptive statistics and Chi-Square test were performed in SPSS version 16.00 with a significance level of p<0.05.

Results

Bacterial isolates and determination of antibiotic susceptibility

In this cross-sectional study, 85 non-duplicated A. baumannii isolates were collected from the different clinical samples, including burn wounds 22 (25.88%), tracheal secretion 31 (36.47%), blood 16 (18.82%), bronchial lavage 12 (14.11%) and urine 4 (4.7%) isolates and the mean age of the patients was 62.1±4.75 years. According to antibiotic susceptibility testing, 77 out of 85 (90.58%) A. baumannii isolates were identified as MDR.

In our study, among 77 MDR A. baumannii isolates, resistance to amikacin, ceftazidime, ceftriaxone, cefepime, ciprofloxacin, cefotaxime, gentamicin, imipenem, meropenem, piperacillin/tazobactam, piperacillin, ampicillin/sulbactam, trimethoprim/sulfamethoxazole and tetracycline was seen in 71 (92.2%), 75 (97.4%), 76 (98.7%), 75 (97.4%), 75 (97.4%), 76 (98.7%), 76 (98.7%), 69 (89.6%), 73 (94.8%), 75 (97.4%), 75 (97.4%), 43 (55.8%), 74 (96.1%) and 47 (61.03%) isolates, respectively. Also, all isolates were sensitive to polymyxin B and only two isolates were resistant to colistin. The MICs of carbapenems and colistin among 85 A.baumanni isolates are shown in Table 1.

Table 1.

Distribution of resistance to meropenem, imipenem and colistin with regard to ERIC PCR types among 85 A. baumannii isolates

Strain Type IMI MEM COL Strain Type IMI MEM COL
SF01 ST01 16 32 0.5 SF44 CT13 64 32 1
SF02 CT01 64 128 1 SF45 CT14 128 64 0.25
SF03 CT01 64 128 1 SF46 CT14 128 64 0.25
SF04 ST02 128 64 0.5 SF47 CT14 128 64 0.25
SF05 ST03 256 64 1 SF48 CT14 128 64 0.25
SF06 CT02 1 1 2 SF49 CT14 128 64 0.25
SF07 CT02 1 1 2 SF50 ST13 64 64 1
SF08 CT02 1 1 2 SF51 ST14 32 64 8
SF09 ST04 32 64 0.5 SF52 ST15 128 512 0.5
SF10 CT03 0.5 0.5 0.5 SF53 CT15 32 128 1
SF11 CT03 0.5 0.5 0.5 SF54 CT15 32 128 1
SF12 ST05 32 64 4 SF55 CT15 32 128 1
SF13 ST06 128 64 1 SF56 CT15 32 128 1
SF14 CT04 2 2 2 SF57 CT16 16 64 0.25
SF15 CT04 2 2 2 SF58 CT16 16 64 0.25
SF16 CT05 64 256 0.5 SF59 CT16 16 64 0.25
SF17 CT05 64 256 0.5 SF60 CT16 16 64 0.25
SF18 CT05 64 256 0.5 SF61 CT16 16 64 0.25
SF19 CT06 32 64 0.25 SF62 CT16 16 64 0.25
SF20 CT06 32 64 0.25 SF63 CT17 256 512 0.5
SF21 CT06 32 64 0.25 SF64 CT17 256 512 0.5
SF22 CT07 2 2 1 SF65 CT17 256 512 0.5
SF23 CT07 2 2 1 SF66 CT17 256 512 0.5
SF24 CT08 2 4 1 SF67 ST16 64 128 2
SF25 CT08 2 4 1 SF68 CT18 32 64 1
SF26 ST07 0.5 0.5 2 SF69 CT18 32 64 1
SF27 CT09 1 1 1 SF70 CT18 32 64 1
SF28 CT09 1 1 1 SF71 CT19 512 128 2
SF29 ST08 128 64 0.5 SF72 CT19 512 128 2
SF30 ST09 512 256 0.5 SF73 CT19 512 128 2
SF31 CT10 16 32 0.5 SF74 CT19 512 128 2
SF32 CT10 16 32 0.5 SF75 ST17 64 32 1
SF33 ST10 512 256 2 SF76 ST18 32 128 0.5
SF34 ST11 32 64 1 SF77 ST19 512 64 0.25
SF35 ST12 128 64 1 SF78 ST20 128 64 2
SF36 CT11 16 64 0.5 SF79 CT20 1 1 1
SF37 CT11 16 64 0.5 SF80 CT20 1 1 1
SF38 CT11 16 64 0.5 SF81 CT21 32 64 2
SF39 CT11 16 64 0.5 SF82 CT21 32 64 2
SF40 CT11 16 64 0.5 SF83 ST21 16 32 2
SF41 CT12 32 128 2 SF84 ST22 32 64 0.5
SF42 CT12 32 128 2 SF85 ST23 128 512 0.25
SF43 CT13 64 32 1

Abbreviations: CT, clone type; ST, single type; MEM, Meropenem; IMI, Imipenem; COL, Colistin.

ERIC-PCR analysis

In our study, 85 A.baumanni isolates were classified into 21 clone types and 23 single type of ERIC-PCR. Figure 1 is shown the dendrogram of ERIC-PCR of these isolates. Also, Table 1 shows the distribution of MICs of imipenem, meropenem and colistin among these isolates with respect to ERIC-PCR types. According to these results, there was a significant association (p<0.05) between the clone types and antibiotic susceptibility to carbapenem agents and colistin.

Figure 1.

Figure 1

Dendrogram of 85 A. baumannii clinical isolates based on ERIC-PCR types.

Abbreviations: CT, clone type; ST, single type; W, burn wound; T, tracheal secretion; B, blood; BL, bronchial lavage; U, urine; Hospital A, Imam Khomeini; B, Taleghani Hospital.

Detection of genes encoding MBLs and intI1 and intI2

In our study, the frequency rates of the genes encoding blaIMP, blaVIM, blaSIM and blaSPM, among 77 MDR A. baumannii isolates were 10 (12.98%), 17 (22.07%), 2 (2.59%) and 4 (5.19%), respectively. In addition, none of the genes encoding blaGIM, blaDIM and blaNDM was detected in these isolates. Also, none of the genes encoding MBLs was detected in non-MDR isolates.

Moreover, 7 isolates carried only the blaIMP gene derivatives, 14 carried only the blaVIM gene derivatives, 3 carried both the blaVIM and blaIMP genes derivatives, 4 carried only the blaSPM-1 gene and 2 carried only the blaSIM-1 gene. The distribution of allelic variants of blaIMP and blaVIM is shown in Table 2. According to these results, blaVIM-2 was the most prevalent variant of blaVIM gene. In this study, the amplification of the intI 1 and intI2 genes was performed using PCR. Of the 77 MDR A. baumannii isolates, 34 had only intI 1, 10 had only int 2 and 15 had both the intI 1 and intI 2 genes.

Table 2.

Pattern of allelic variants of blaIMP and blaVIM

blaVIM blaVIM-1 (5 strains)
blaVIM-2(9 strains)
blaVIM-25(3 strains)
blaIMP blaIMP- 4 (5 strains)
blaIMP-19(5 strains)

Association of phenotypic detection of MBL production with genes encoding MBLs

Among 73 carbapenem-resistant A. baumannii isolates, 30 were phenotypically as MBL-producing isolates. Moreover, of these 30 isolates, 7 carried only the blaIMP gene derivatives, 14carried only the blaVIM gene derivatives, 2 carried both the blaVIM and blaIMP gene derivatives, 4 carried the blaSPM-1 gene and 2 carried the blaSIM-1 gene. However, one strain did not carry any gene encoding MBL. Overall, 29 isolates presenting MBL phenotype carried at least one of the MBL genes, confirming the efficacy of the phenotypic detection of MBL producing strains with the PCR results.

On the other hand, the phenotypic detection of MBL was negative for one blaVIM positive A. baumannii isolate and one blaIMP positive isolates.

Association of the presence of integrons with genes encoding MBLs among MDR A. baumannii

Table 3 indicates the distribution of gene cassettes carrying MBLs among integron-positive A.baumannii isolates. Eight gene cassette arrays were detected within class 1 integron and three gene cassette arrays within class 2 integron. The most prevalent gene cassette arrays among positive class 1 integron isolates, blaIMP-19,aacA31, blaOXA-21,aadA-1 and blaVIM-1,qacED-1, were detected among 10 isolates. According to these results, blaVIM allelic variants were as the part of gene cassettes incorporated into class 1 integron among 10 isolates and as the part of gene cassettes in class 2 integron among 2 isolates. On the other hand, blaIMP derivatives were as the part of gene cassettes incorporated into class 1 integron among 4 isolates and into class 2 integron among 1 isolate. Also, 2 isolates carried both blaVIM and blaIMP allelic variants in gene cassettes incorporated into class 1 integron and one isolate carried only blaIMP in gene cassette incorporated into class 1 integron. In addition, 2 isolates carring blaVIM and 2 isolates carring blaIMP were lack either intI1 or intI2.

Table 3.

Distribution of gene cassettes carrying MBLs among integron-positive A.baumannii isolates

Strain No. Type IntI1 and gene cassette IntI2 and gene cassette
SF45 CT14 blaVIM-1,qacED-1
SF46 CT14 blaVIM-1,qacED-1
SF47 CT14 blaVIM-1,qacED-1
SF48 CT14 blaVIM-1,qacED-1
SF49 CT14 blaVIM-1,qacED-1
SF02 CT01 GES-11, blaIMP-4, blaVIM-2
SF03 CT01 GES-11, blaIMP-4, blaVIM-2
SF12 ST05 blaIMP-19,aacA31, blaOXA-21,aadA-1
SF71 CT19 blaIMP-19,aacA31, blaOXA-21,aadA-1
SF72 CT19 blaIMP-19,aacA31, blaOXA-21,aadA-1
SF73 CT19 blaIMP-19,aacA31, blaOXA-21,aadA-1
SF74 CT19 blaIMP-19,aacA-31, blaOXA-21,aadA-1
SF41 CT12 blaVIM-25, GES-24, qacED-1
SF42 CT12 blaVIM-25, GES-24, qacED-1
SF68 CT18 blaVIM-2, aacA-7, aadA-1, qacED-1 DfrA-1, SAT-2, aadA-1
SF69 CT18 blaVIM-2, aacA-7, aadA-1, qacED-1 DfrA-1, SAT-2, aadA-1
SF70 CT18 blaVIM-2., aacA-7, aadA-1, qacED-1 DfrA-1, SAT-2, aadA-1
SF34 ST11 blaVIM-25, GES-24, qacED-1
SF81 CT21 arr-2, cmlA-7, sul-1, qacED-1 blaVIM-2, blaVEB, aacA4
SF82 CT21 arr-2, cmlA-7, sul-1, qacED-1 blaVIM-2, blaVEB, aacA4
SF43 CT13 blaSIM-1,Arr-3, aadA-1, qacED-1, sul-1
SF44 CT13 blaSIM-1,Arr-3, aadA-1, qacED-1, sul-1
SF53 CT15 blaSPM-1, aacA-2, aadA-1
SF54 CT15 blaSPM-1, aacA-2, aadA-1
SF55 CT15 blaSPM-1, aacA-2, aadA-1
SF56 CT15 blaSPM-1, aacA-2, aadA-1
SF85 ST23 blaIMP-4

Abbreviations: CT, clone type; MBL, Metallo-β-Lactamase; ST, single type.

According to the results shown in Table 3, the isolates belonging to a same clone type had the similar gene cassette array in class 1 and 2 integron.

Discussion

A.baumannii is an important nosocomial pathogen with the high associated mortality. In the last few years, the resistance to the almost commonly prescribed antibiotics among A.baumannii strains is increasing which will cause a treatment challenge in the future.25

The results of our study showed that 90.58% of A. baumannii isolates were MDR. In agreement with our results, the high prevalence of MDR A. baumannii isolates was reported from other studies, ranged from 49.6% to 100%.2631The multidrug antibiotic resistance has often limited the efficacy of the common therapeutic options especially for the strains that are resistant to carbapenems. In the current study, the resistance rates to carbapenem agents (imipenem or meropenem) were similar to a previous study by Shoja et al32 in the same region during 2011 to 2012 years, indicating that the prevalence of MDR A.baumannii isolates is still high in our region.

Our results showed that the antibiotic resistance rates to amikacin, ceftazidime, ceftriaxone, cefepime, ciprofloxacin, cefotaxime, gentamicin, meropenem, piperacillin/tazobactam and piperacillin among MDR A. baumannii strains were more than 90%. Similar to our work, Mirnejad et al33, Huang et al5 and Taherikalani et al34 also reported the high percentages of the antibiotic resistance among A. baumannii isolates.

As mentioned earlier, polymyxins are recommended as the antibiotic choices for MDR A. baumannii infections. In our study, all isolates were susceptible to polymyxin B which was in concordance with the studies conducted by Najar Peerayeh et al35 and Shoja et al32 in Iran. However, in contrast to our results, the higher resistance rates to polymyxin B were reported in other regions of Iran, including 14% in Tehran,36 16% in Tabriz37 and 11% in Kermanshah.38 It seems that this growing resistance could be due to the excessive usage of this antibiotic in the treatment of severe infections. Surprisingly, the resistance level to polymyxin B in Brazil39 was much high (81.5%). This high resistance might be due to the prolonged use of this antibiotic agent in treatment of carbapenem-resistant A. baumannii infections in this country.39 Our results showed that the majority of A. baumannii isolates were susceptible to colistin which is in agreement with a previous study32 in our region, suggesting polymyxin B and colistin are still the most effective antibiotic agents against MDR A. baumannii strains.

In our study, the blaIMP and blaVIM allelic variants were recognized as the most common genes encoding MBLs in the majority of isolate with the positive results in the phenotypic detection of MBL. However, in the one isolate that was phenotypically positive for MBL production, any gene encoding MBL was not detected using PCR. It seems that MBL phenotype in this isolate was caused by other mechanisms rather than the presence of genes encoding MBLs that unfortunately were not considered in our study.

In consistent with our work, Lee et al40 in Seoul found the blaIMP and blaVIM genes allelic variants in most A.baumannii isolates, whereas the blaSIM-1 gene was recognized only in a few isolates. However, in contrast to our results, Shahcheraghi et al41 in Iran did not find either blaIMP or blaVIM genes, instead the blaSPM gene was recognized in the A. baumannii isolates.

In our study, the phenotypic detection of MBL was negative in one blaVIM -positive isolate and one blaIMP - positive isolate. Similar to our study, Ikonomidis et al42 also, reported two A. baumannii isolates harboring blaVIM-1 gene which were phenotypically negative for MBL production. Moreover, to find the reason of this phenomenon, the researchers evaluated the blaVIM-1 expression in these two isolates, indicating that one of these isolates had a weak P1 promoter, and both these isolates had the inactivated P2 promoters. Hence, the blaVIM-1 expression level was reduced significantly and these isolates showed a negative phenotype in MBL test.

The integrons as the mobile genetic elements play an important role in the dissemination of antibiotic resistance determinants among A.baumannii isolates. In recent years, the frequency rates of integrons are increasing, so that they have caused a serious threat for the spread of antibiotic resistance elements.43

In our study, the prevalence of the intI1 gene was more than the intI2 gene that is in agreement with the results obtained from studies of Huang et al5 in China, Japoni et al44 and Taherikalani et al34 in Iran. However, unlike our study, Mirnejad et al33 in Tehran and Ramírez et al43 in Buenos Aires found higher frequency of the intI2 gene than the intI1 gene. The difference in data is often dependent on the integron classes of clones which are widely disseminated in the community and nosocomial settings.

Our results showed that class 1 integron is often responsible for transferring the gene cassettes harboring MBLs, especially the blaVIM and blaIMP allelic variants. In consistent with our results, Tsakris et al45 and Mendes et al46 associated the presence of class 1 integron with gene cassettes encoding blaVIM and blaIMP allelic variants. Moreover, Mendes et al indicated the presence of the blaIMP-1 gene in the gene cassette of blaIMP1_ aac(6)-31_ aadA1 which was plasmid located in five of the seven isolates. Also, Goudarzi et al47 showed the presence of gene cassettes encoding blaVIM and blaIMP allelic within both class 1 and 2 integrons, suggesting the class 1 integron has the important role in the horizontal transfer of gene cassettes encoding MBLs.46

In our study, the most prevalent gene cassette arrays among positive class 1 integron and MBLs isolates were blaIMP-19_aacA31_blaOXA-21_aadA-1 and blaVIM-1_qacED-1.

In consistent with our results, Goudarzi et al47 showed seven different gene cassettes in 89 class 1 integron-carrying isolates and three gene cassettes in 15 class 2 integron-harboring A. baumannii isolates that among them, five different gene cassettes harbored gene encoding MBLs (VIM-25-GES-24-qacF, IMP-4, VIM-2-VEB-aacA4 and GES-11-IMP-4-VIM-2).

In our study, the majority of gene cassettes encoding MBL genes harbored genes encoding resistance to aminoglycosides as shown in a previous study by Farshadzadeh et al.48 Moreover, they indicated that gene cassettes encoding resistance to aminoglycosides were present in the majority of MDR A. baumannii isolates, suggesting the high-level resistance rates to aminoglycoside agents among A. baumannii isolates.

Also, according to the results obtained from ERIC-PCR analysis, the isolates belonging to a same clone type had the similar gene cassette array in class 1 and 2 integrons, indicating the importance of molecular typing methods in epidemiological studies for finding the distribution of clonal types disseminated in a hospital or a geographical region.

Conclusion

We demonstrated a high prevalence of resistance to carbapenems, as well as the genes encoding MBLs among MDR A. baumannii isolates. Hence, the results of our study showed that MBLs have an important role in the resistance to carbapenem among MDR A. baumannii isolates. Therefore, the development of simple and inexpensive screening methods for detecting MBL production in microbiology laboratories is essential. In this study, we indicated polymyxins as the only option of effective antibiotic in vitro against MDR A. baumannii isolates. Also, our data revealed that the class I integron had a significant role in the dissemination of blaVIM gene among clinical isolates of A. baumannii in Ahvaz, Iran.

Acknowledgments

This work is a part of M. Sc. thesis of Farkhondeh Saleh Shooshtari which has been approved in the Department of Microbiology of Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. The authors thank the Health Research Institute, Infectious and Tropical Diseases Research Center, Jundishapur University of Medical Sciences, Ahvaz, Iran for financial support. This study was supported by funds from Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Author contributions

All authors contributed to data analysis, drafting and revising the article, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.

Disclosure

The authors report no conflicts of interest in this work.

References

  • 1.Ghajavand H, Esfahani BN, Havaei SA, Moghim S, Fazeli H. Molecular identification of Acinetobacter baumannii isolated from intensive care units and their antimicrobial resistance patterns. Adv Biomed Res. 2015;4:110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hanlon GW. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting. Lett Appl Microbiol. 2005;41(5):375–378. doi: 10.1111/j.1472-765X.2005.01791.x [DOI] [PubMed] [Google Scholar]
  • 3.Gillings MR. Integrons: past, present, and future. Microbiol Mol Biol Rev. 2014;78(2):257–277. doi: 10.1128/MMBR.00056-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Martins N, Picão RC, Adams-Sapper S, Riley LW, Bm M. Association of class 1 and 2 integrons with multidrug-resistant Acinetobacter baumannii international clones and Acinetobacter nosocomialis isolates. Antimicrob Agents Chemother. 2015;59(1):698–701. doi: 10.1128/AAC.02415-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Huang C, Long Q, Qian K, et al. Resistance and integrin characterization of Acinetobacter baumannii in a teaching hospital in Chongqing, China. New Microbes New Infect. 2015;8:103–108. doi: 10.1016/j.nmni.2015.09.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Quale J, Bratu S, Landman D, Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis. 2003;37(2):214–220. doi: 10.1086/375875 [DOI] [PubMed] [Google Scholar]
  • 7.Tsakris A, Poulou A, Kristo I, et al. Large dissemination of VIM-2-metallo-{beta}-lactamase-producing pseudomonas aeruginosa strains causing health care-associated community-onset infections. J Clin Microbiol. 2009;47(11):3524–3529. doi: 10.1128/JCM.01099-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bebrone C. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem Pharmacol. 2007;74(12):1686–1701. doi: 10.1016/j.bcp.2007.05.021 [DOI] [PubMed] [Google Scholar]
  • 9.Khosravi Y, Tay ST, Vadivelu J. Analysis of integrons and associated gene cassettes of metallo-β-lactamase-positive Pseudomonas aeruginosa in Malaysia. J Med Microbiol. 2011;60(Pt7):988–994. doi: 10.1099/jmm.0.029868-0 [DOI] [PubMed] [Google Scholar]
  • 10.Anoar KA, Ali FA, Omer SA. Detection of metallo [Beta]-lactamase enzyme in somegram negative bacteria isolated from burn patients in Sulaimani city, Iraq. Eur Sci J. 2014;10(3):485–496. [Google Scholar]
  • 11.Zavascki AP, Goldani LZ, Li J, Nation RL. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother. 2007;60(2):1206–1215. doi: 10.1093/jac/dkm357 [DOI] [PubMed] [Google Scholar]
  • 12.Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother. 1999;33(9):960–967. doi: 10.1345/aph.18426 [DOI] [PubMed] [Google Scholar]
  • 13.Hall GS. Non-fermenting and miscellaneous gram-negative bacilli In: Mahon CR, Lehman DC, Manuselis G, Heights M, editors. Textbook of Diagnostic Microbiology. 4th ed. Mo: Saunders/Elsevier; 2011:482–501. [Google Scholar]
  • 14.Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44:2974–2976. doi: 10.1128/JCM.01021-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.CLSI. M100-S28. Performance standards for antimicrobial susceptibility testing; Twenty-eight informational supplement; 2018.
  • 16.Manchanda V, Sanchaita S, Singh N. Multidrug resistant acinetobacter. J Glob Infect Dis. 2010;2(3):291–304. doi: 10.4103/0974-777X.68538 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002;40(10):3798–3801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tavakol M, Momtaz H, Mohajeri P, Shokoohizadeh L, Tajbakhsh E. Genotyping and distribution of putative virulence factors and antibiotic resistance genes of Acinetobacter baumannii strains isolated from raw meat. Antimicrob Resist Infect Control. 2018;7:120. doi: 10.1186/s13756-018-0405-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Koeleman JGM, Stoof J, Van Der Bijl MW, Cmje V-G, Savelkoul PHM. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol. 2001;39(1):8–13. doi: 10.1128/JCM.39.1.8-13.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Fallah F, Noori M, Hashemi A, et al. Prevalence of blaNDM, blaPER, blaVEB, blaIMP, and blaVIM Genes among Acinetobacter baumannii Isolated from Two Hospitals of Tehran, Iran. Scientifica (Cairo). 2014;245162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Aksoy MD, Çavuşlu Ş, Tuğrul HM. Investigation of Metallo Beta lactamases and oxacilinases in carbapenem resistant Acinetobacter baumannii strains isolated from inpatients. Balkan Med J. 2015;32(1):79–83. doi: 10.5152/balkanmedj.2015.15302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Mlynarcik P, Roderova M, Kolar M. Primer evaluation for PCR and its application for detection of carbapenemases in enterobacteriaceae. Jundishapur J Microbiol. 2016;9(1):e29314. doi: 10.5812/jjm [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Moura A, Henriques I, Ribeiro R, Correia A. Prevalence and characterization of integrons from bacteria isolated from a slaughterhouse wastewater treatment plant. J Antimicrob Chemother. 2007;60(6):1243–1250. doi: 10.1093/jac/dkm340 [DOI] [PubMed] [Google Scholar]
  • 24.Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870–1874. doi: 10.1093/molbev/msw054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gaynes R, Edwards JR. National nosocomial infections surveillance system. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41(6):848–854. doi: 10.1086/444499 [DOI] [PubMed] [Google Scholar]
  • 26.Banerjee T, Mishra A, Das A, Sharma S, Barman H, Yadav G. High prevalence and endemicity of multidrug resistant Acinetobacter spp. in intensive care unit of a tertiary care Hospital, Varanasi, India. J Pathog. 2018;2018:9129083. doi: 10.1155/2018/9129083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Begum S, Hasan F, Hussain S, Ali Shah A. Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from Tertiary Care Hospital in Islamabad, Pakistan. Pak J Med Sci. 2013;29(5):1253–1258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.De Francesco MA, Ravizzola G, Peroni L, Bonfanti C, Manca N. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital. J Infect Public Health. 2013;6(3):179–185. doi: 10.1016/j.jiph.2012.11.006 [DOI] [PubMed] [Google Scholar]
  • 29.Tuan Anh N, Nga TV, Tuan HM, et al. Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern VIETNAM. J Med Microbiol. 2017;66(1):46–53. doi: 10.1099/jmm.0.000418 [DOI] [PubMed] [Google Scholar]
  • 30.Shrestha S, Tada T, Miyoshi-Akiyama T, et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage. Int J Antimicrob Agents. 2015;46(5):526–531. doi: 10.1016/j.ijantimicag.2015.07.012 [DOI] [PubMed] [Google Scholar]
  • 31.Castilho SRA, Godoy CSM, Guilarde AO, et al. Acinetobacter baumannii strains isolated from patients in intensive care units in Goiânia, Brazil: molecular and drug susceptibility profiles. PLoS One. 2017;12(5):e0176790. doi: 10.1371/journal.pone.0176790 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Shoja S, Moosavian M, Rostami S, et al. Dissemination of carbapenem-resistant Acinetobacter baumannii in patients with burn injuries. J Chin Med Assoc. 2017;80(4):245–252. doi: 10.1016/j.jcma.2016.10.013 [DOI] [PubMed] [Google Scholar]
  • 33.Mirnejad R, Mostofi S, Masjedian F. Antibiotic resistance and carriage class 1and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran,Iran. Asian Pac J Trop Biomed. 2013;3(2):140–145. doi: 10.1016/S2221-1691(13)60038-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Taherikalani M, Fatolahzadeh B, Emaneini M, Soroush S, Mm F. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. New Microbiol. 2009;32(3):265–271. [PubMed] [Google Scholar]
  • 35.Najar Peerayeh S, Karmostaji A. Molecular identification of resistance determinants, integrons and genetic relatedness of extensively drug resistant Acinetobacter baumannii isolated from hospitals in Tehran, Iran. Jundishapur J Microbiol. 2015;8(7):e27021. doi: 10.5812/jjm [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bahador A, Taheri M, Pourakbari B, et al. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Microb Drug Resist. 2013;19(5):397–406. doi: 10.1089/mdr.2012.0233 [DOI] [PubMed] [Google Scholar]
  • 37.Aliakbarzade K, Farajnia S, Karimi Nik A, Zarei F, Tanomand A. Prevalence of aminoglycoside resistance genes in Acinetobacter baumannii isolates. Jundishapur J Microbiol. 2014;7(10):e11924. doi: 10.5812/jjm.11924 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Mohajeri P, Farahani A, Feizabadi MM, Ketabi H, Abiri R, Najafi F. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iran J Microbiol. 2013;5(3):195–202. [PMC free article] [PubMed] [Google Scholar]
  • 39.Genteluci GL, Gomes DB, Souza MJ, Carvalho KR, Villas-Bôas MH. Emergence of polymyxin B-resistant Acinetobacter baumannii in hospitals in Rio de Janeiro. J Bras Patol Med Lab. 2016;52(2):91–95. [Google Scholar]
  • 40.Lee K, Yum JH, Yong D, et al. Novel acquired metallobeta- lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother. 2005;49(11):4485–4491. doi: 10.1128/AAC.49.11.4485-4491.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol. 2011;3(2):68–74. [PMC free article] [PubMed] [Google Scholar]
  • 42.Ikonomidis A, Ntokou E, Maniatis AN, Tsakris A, Pournaras S. Hidden VIM-1 metallobeta-lactamase phenotypes among Acinetobacter baumannii clinical isolates. J Clin Microbiol. 2008;46(1):346–349. doi: 10.1128/JCM.01670-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ramírez MS, Stietz MS, Vilacoba E, et al. Increasing frequency of class 1 and 2 integrons in multidrug-resistant clones of Acinetobacter baumannii reveals the need for continuous molecular surveillance. Int J Antimicrob Agents. 2011;37(2):175–177. doi: 10.1016/j.ijantimicag.2010.10.006 [DOI] [PubMed] [Google Scholar]
  • 44.Japoni S, Japoni A, Farshad S, Ali AA, Jamalidoust M. Association between existence of integrons and multi-drug resistance in Acinetobacter isolated from patients in southern Iran. Pol J Microbiol. 2011;60(2):163–168. [PubMed] [Google Scholar]
  • 45.Tsakris A, Ikonomidis A, Pournaras S, et al. VIM-1 metallo-beta-lactamase in Acinetobacter baumannii. Emerg Infect Dis. 2006;12(6):981–983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Mendes RE, Castanheira M, Toleman MA, Sader HS, Jones RN, Walsh TR. Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6‘)-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital. Antimicrob Agents Chemother. 2007;51(7):2611–2614. doi: 10.1128/AAC.00838-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Goudarzi H, Azad M, Seyedjavadi SS, et al. Characterization of integrons and associated gene cassettes in Acinetobacter baumannii strains isolated from intensive care unit in Tehran, Iran. J Acute Dis. 2016;5(5):386–392. doi: 10.1016/j.joad.2016.08.004 [DOI] [Google Scholar]
  • 48.Farshadzadeh Z, Hashemi FB, Rahimi S, et al. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front Microbiol. 2015;6:1146. doi: 10.3389/fmicb.2015.01146 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Drug Resistance are provided here courtesy of Dove Press

RESOURCES